(Q37067704)

18 August 2017

1 reference

title

Weight gain and metabolic issues of medicines used for bipolar disorder (English)

1 reference

18 August 2017

1 reference

1 reference

1

Andrea Fagiolini

1 reference

18 August 2017

K N Roy Chengappa

2

1 reference

PubMed ID

18221634

18 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Current Psychiatry Reports

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

6

1 reference

18 August 2017

521-528

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-007-0071-1

18 August 2017

0 references

cites work

Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0071-1

Stable weight during lamotrigine therapy: a review of 32 studies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0071-1

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0071-1

The increasing medical burden in bipolar disorder

21 January 2018

1 reference

12 December 2020

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

1 reference

12 December 2020

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

1 reference

12 December 2020

Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs

1 reference

12 December 2020

Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

1 reference

12 December 2020

Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

1 reference

12 December 2020

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Lithium: a review of its metabolic adverse effects

1 reference

12 December 2020

Quetiapine-associated hyperglycemia and hypertriglyceridemia

1 reference

12 December 2020

Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment

1 reference

12 December 2020

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

1 reference

12 December 2020

Characterization of insulin secretion in Valproate-treated patients with epilepsy.

1 reference

12 December 2020

Burden of general medical conditions among individuals with bipolar disorder

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Lithium, weight gain, and serum insulin in manic-depressive patients

1 reference

12 December 2020

Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial

1 reference

12 December 2020

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

12 December 2020

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

12 December 2020

Lithium and body weight gain.

1 reference

12 December 2020

Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

12 December 2020

Adenyl cyclase in fat cells. 1. Properties and the effects of adrenocorticotropin and fluoride.

1 reference

12 December 2020

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

1 reference

12 December 2020

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

12 December 2020

Transient diabetes associated with withdrawal of lithium therapy.

1 reference

12 December 2020

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

1 reference

12 December 2020

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

12 December 2020

Relative weight gain among antipsychotics

1 reference

12 December 2020

Valproate, weight gain and carbohydrate craving: a gender study

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Medication-induced hyperprolactinemia

1 reference

12 December 2020

Olanzapine-associated diabetes mellitus

1 reference

12 December 2020

Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Disorders of prolactin secretion

1 reference

12 December 2020

Bodyweight gain and anticonvulsants: a comparative review

1 reference

12 December 2020

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

1 reference

12 December 2020

1 reference

12 December 2020

The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence

1 reference

12 December 2020

Psychiatric disorders and neural mechanisms underlying energy intake and expenditure: a review

1 reference

12 December 2020

Novel antipsychotics and severe hyperlipidemia

1 reference

12 December 2020

Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.

1 reference

12 December 2020

A study of quetiapine: efficacy and tolerability in psychotic adolescents

1 reference

12 December 2020

Obesity as a correlate of outcome in patients with bipolar I disorder

1 reference

12 December 2020

A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes

1 reference

12 December 2020

Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment

1 reference

12 December 2020

Lithium--a role in hyperlipidemia?

1 reference

12 December 2020

Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

1 reference

12 December 2020

Weight gain in the treatment of mood disorders

1 reference

12 December 2020

Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder

1 reference

12 December 2020

Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?

1 reference

12 December 2020

Safety and tolerability of emerging pharmacological treatments for bipolar disorder

1 reference

12 December 2020

Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder

1 reference

12 December 2020

Risperidone-associated diabetes mellitus: a pharmacovigilance study

1 reference

12 December 2020

Suicide attempts and ideation in patients with bipolar I disorder.

1 reference

12 December 2020

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

1 reference

12 December 2020

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

1 reference

12 December 2020

10.1007/S11920-007-0071-1

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18221634